Correction of anaemia on dialysis: Did we forget physiology?

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1120-1122

  Hertig, Alexandre ^a   Ferrer Marin, Francisca ^b  

^a HÔPITAL TENON   (France)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ACIDOSIS; ANEMIA; ARTICLE; DIALYSIS; ERYTHROCYTE; FLUID BALANCE; HEMATOCRIT; HUMAN; IRON OVERLOAD; KIDNEY FAILURE; OXYGEN AFFINITY; OXYGEN CONSUMPTION; OXYGEN DISSOCIATION CURVE; OXYGEN SATURATION; OXYGENATION; PH; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; RISK MANAGEMENT; SENSITIZATION; UREMIA;

ANEMIA; ERYTHROPOIETIN; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 79953887824     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr001     Document Type: Article

References (24)

1. Eschbach JW, Egrie JC, Downing MR et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316: 73-78. (Pubitemid 17052741)
2. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590 (Pubitemid 28385655)
3. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098 (Pubitemid 44749317)
4. Pfeffer MA, Burdmann EA, Chen CYet al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-2032
5. Kimel M, Leidy NK, Mannix S et al. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health 2008; 11: 57-75 (Pubitemid 351160877)
6. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084 (Pubitemid 44749316)
7. Ma JZ, Ebben J, Xia H et al. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619 (Pubitemid 29117643)
8. Sinclair AM, Coxon A, McCaffery I et al. Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 2010; 115: 4264-4272
9. Unger EF, Thompson AM, Blank MJ et al. Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med 2010; 362: 189-192
10. Treacher DF, Leach RM. Oxygen transport-1. Basic principles. BMJ 1998; 317: 1302-1306
11. Blumberg A, Marti HR. Adaptation to anemia by decreased oxygen affinity of hemoglobin in patients on dialysis. Kidney Int 1972; 1: 263-270
12. Mitchell TR, Pegrum GD. The oxygen affinity of haemoglobin in chronic renal failure. Br J Haematol 1971; 21: 463-472
13. Lichtman MA, Murphy MS, Byer BJ et al. Hemoglobin affinity for oxygen in chronic renal disease: the effect of hemodialysis. Blood 1974; 43: 417-424
14. Szwed JJ, Luft FC, Boykin JR et al. Effect of hemodialysis on oxygen-hemoglobin affinity in chronic uremics. Chest 1974; 66: 278-281
15. Monti JP, Gallice P, Murisasco A et al. Phosphorus-31 and water proton relaxation in living erythrocytes. Application to uremia. Biochim Biophys Acta 1989; 1010: 210-217 (Pubitemid 19050026)
16. Egger U, Blumberg A, Marti HR. Acid-base balance and oxygen affinity of hemoglobin in patients on maintenance dialysis. Clin Nephrol 1972; 1: 70-75
17. Monti JP, Brunet PJ, Berland YF et al. Opposite effects of urea on hemoglobin-oxygen affinity in anemia of chronic renal failure. Kidney Int 1995; 48: 827-831
18. Ando R, Saito H, Takeuchi J. Factors that affect oxygen affinity of hemoglobin in chronic hemodialysis patients. Nephron 1987; 46: 268-272 (Pubitemid 17081110)
19. Haidas S, Labie D, Kaplan JC. 2,3-diphosphoglycerate content and oxygen affinity as a function of red cell age in normal individuals. Blood 1971; 38: 463-467
20. Brunet P, Berland Y, Merzouk T et al. Effect of recombinant human erythropoietin treatment in uremic patients on oxygen affinity of hemoglobin. Nephron 1994; 66: 147-152 (Pubitemid 24028052)
21. Bocker A, Reimers E, Nonnast-Daniel B et al. Effect of erythropoi-etin treatment on O2 affinity and performance in patients with renal anemia. Contrib Nephrol 1988; 66: 165-175
22. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530
23. Locatelli F, Nissenson AR, Barrett BJ et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2008; 74: 1237-1240
24. Singh AK. Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol 2010; 21: 2-6